Pyoderma gangrenosum. Report of three cases in plastic surgery;Pioderma gangrenosa en cirugía plástica: Comunicación de tres casos

Revista Medica de Chile

Volumn 134, Issue 3, 2006, Pages 339-344

  Eulufí M, Alex ^a   Calderón O, Wilfredo ^a   Piñeros B, José Luis ^a   Silva C, Macarena ^b   Cuadra C, Alvaro ^a   Léniz M, Patricio ^a,c   Gómez S, Lyonel ^d   Eulufí M, Christian ^e   Calderón M, Daniel ^f  

^a HOSPITAL DEL TRABAJADOR   (Chile)

^b HOSPITAL SAN BORJA ARRIARÁN   (Chile)

^c UNIVERSIDAD DIEGO PORTALES   (Chile)

^d HOSPITAL MILITAR DE SANTIAGO   (Chile)

^e UNIVERSIDAD ANDRÉS BELLO   (Chile)

^f UNIVERSIDAD MAYOR   (Chile)

Author keywords

Pyodema gangrenosum; Skin diseases, vascular

Indexed keywords

CORTICOSTEROID;

ARTICLE; BREAST RECONSTRUCTION; CASE REPORT; FEMALE; HUMAN; HYPERBARIC OXYGEN; MALE; MIDDLE AGED; PLASTIC SURGERY; PYODERMA GANGRENOSUM; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; FEMALE; HUMANS; HYPERBARIC OXYGENATION; MALE; MAMMAPLASTY; MIDDLE AGED; PYODERMA GANGRENOSUM; SURGICAL FLAPS; TREATMENT OUTCOME;

EID: 33646472404     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. WINES N, WINES M, RYMAN W. Understanding pyoderma gangrenosum: a review. General Med 2001; 27: 6.
2. POWELL FC, SCHROETR AL, SU WPD, PERRY HO. Pyoderma gangrenosum: a review of 86 cases. Q J Med 1985; 55: 173.
3. HEVIA H, SUÁREZ J, VERGERA MT. Pioderma gangrenoso peri ileostómico: caso clínico. Rev Méd Chile 2004; 132: 747-9.
4. VIGNON-PENAMEN M, WALLACH D. Cutaneous manifestation of neutrophilic disease: a study of seven cases. Dermatologica 1991; 183: 255-64.
5. FRANK C, POWELL, FRCPI WP, DAIEL SU MD, HAROLD O, PERRY MD. Continuing medical education. Pyoderma gangrenosum: Classification and management. Journal of the American Academy of Dermatology, Volume 34, number 3, march 1996, 395-409.
6. PERCIVAL GH. Pyoderma gangrenosum: The histology of the primary lesion. Br J Dermatol 1957; 69: 130-6.
7. VAN DER SLUIS I. Two cases of pyoderma (erthyma) gangrenosum associated with the presence of an anormal serum protein- beta 2A (paraprotein): with a review of the literature. Dermatologica 1966; 132: 409-24.
8. THOMPSON DM, MAIN RA, BECK JS, ALBERT-RECHT F. Studies on a patient with leukocitoclastic vasculitis «pyoderma gangrenosum» and paraproteinemia. Br J Dermatol 1973; 88: 117-25.
9. SU WPD, SCHROETER AL, PERRY HO, POWELL FC. histophatologic and inmunopathologic study of pyoderma gangrenosum. J Cutan Pathol 1986; 13: 323-30.
10. CROWSON N, MIHM JR M, MAGRO CM. Pyoderma gangrenosum: a review. J Cutan Pathol 2003; 30: 97-107.
11. POWELL FC, PERRY HO. Pyoderma gangrenosum in childhood. Arch Dermatol 1984; 120: 757-61.
12. BRUNSTING LA, GOECKENMAN WH, O'LEARY PA. Pyoderma gangrenosum: clinical and experimental observations in five cases occurrig in adults. Arch Dermatol 1930; 22: 655.
13. CROWSON AN, MAGRO CM. The pathology of cutaneous drug eruption. Curr Probl Dermathol 2002; 14: 117.
14. GLASS AT, BANCILA E, MILGRAUM S. Pyoderma Gangrenosum in infancy: the youngest reported patient. J Am Acad Dermatol 1991; 25: 109-10.
15. CALLEN JP, WOO TU. Vesicopustular eruption in a patient with ulcerative colitis. Pyoderma gangrenosum. Arch Dermatol 1985; 121: 399-402.
16. th edn. Philadelphia: JB Lippincott, 1997; 353.
17. HURWITZ RM, HAREMAN JM. The evolution of pyoderma gangrenosum: a clinicopathologic correlation. Am J Dermatophatol 1993; 15: 28-33.
18. CHOW RKP, HO VC. Treatment of pyoderma gangrenosum. J Am Acad Dermatol 1996; 34: 1047.
19. ELGART G, STOVER P, LARSON K ET AL. Treatment of pyoderma gangrenosum with cyclosporina: results in seven patients. J Am Acad Dermatol 1991; 24: 83.
20. MATIS WL, ELLIS CN, GRIFFITHS CEM, LAZARUS GS. Treatment of pyoderma gangrenosum with cyclosporina. Arch Dermatol 1992; 128: 1060.
21. RAPINI RP. Cytotoxic drugs in the treatment of skin disease. Int J Dermatol 1991; 30: 313.
22. FAULDS D, GOA KL, BENFIELD P. Cyclosporin: a review of its pharmacodynamics and pharmacokinetics properties and therapeutics use in inmunoregulatory disorders. Drugs 1993; 45: 953-1040.
23. RUZICKA T, ASSMAN T, HAMEY B. Tacrolimus: The drug for the future of the millennium. Arch Dermatol 1999; 135: 574-80.
24. POWELL F, O'KARA M. Management of pyoderma gangrenosum. Dermat Cli 2002(20): 2.
25. KAMIUSKA R, IKAHEIMO R, HOLLMEN A. Plasmapheresis and cyclophosphamide as successful treatments for pyoderma gangrenosum. Clin Exp Dermatol 1999; 24: 81.
26. BEUREY J, CANTON PH, WEBER M ET AL. Pyoderma gangrenosum cervical: traitement par échanges plasmatiques. Ann Dermatol Venereol 1982; 109: 455-9.
27. VON DEN DRIESCH P. Pyoderma gangrenosum: A Report of 44 cases with follow-up. Br J Dermatol 1997; 137: 1000-5.
28. HEVIA H, SUÁREZ J, VERGARA MT. Pioderma gangrenoso periileostómico: caso clínico. Rev Méd Chile 2004; 132: 747-9.